Beta-adrenergic receptors and receptor signaling in heart failure.
about
Alterations in reversible protein histidine phosphorylation as intracellular signals in cardiovascular diseaseThird-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureBoth ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling.GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.Decoding calcium signals involved in cardiac growth and function.Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training.Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema FactorCompartmentation of cAMP signaling in cardiac myocytes: a computational study.The GTP-binding protein RhoA mediates Na,K-ATPase exocytosis in alveolar epithelial cellsEpigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.Neurohumoral activation in heart failure: the role of adrenergic receptors.Pyruvate restores β-adrenergic sensitivity of L-type Ca(2+) channels in failing rat heart: role of protein phosphataseF90927: a new member in the class of cardioactive steroids.Regulation of the trafficking and function of G protein-coupled receptors by Rab1 GTPase in cardiomyocytes.Differential expression of Gs in a murine model of homocysteinemic heart failureAdrenergic signaling and oxidative stress: a role for sirtuins?Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes.Myofibroblasts in the infarct area: concepts and challenges.Chronic prenatal hypoxia sensitizes beta-adrenoceptors in the embryonic heart but causes postnatal desensitization.Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes.The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure.Heterodimerization and surface localization of G protein coupled receptorsChronic verapamil treatment remodels ICa,L in mouse ventricle.Overexpression of beta 1 and beta 2 adrenergic receptors in rat atrial myocytes. Differential coupling to G protein-gated inward rectifier K(+) channels via G(s) and G(i)/o.Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice.Inhibition of G protein-coupled receptor trafficking in neuroblastoma cells by MAP 4 decoration of microtubules.Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.Congestive heart failure in copper-deficient mice.Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure.Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.Prenatal hypoxia programs changes in β-adrenergic signaling and postnatal cardiac contractile dysfunction.New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
P2860
Q26782883-A53AE735-EBBE-4EE9-9FDA-E9C9ECFC3B98Q26822825-652DE664-BAC8-4574-B6B1-601018C410FDQ33269156-C988B4BA-D628-4A7C-B308-DCBAE4CAD4ABQ33803705-F9D4499D-C93E-4768-83B1-E72C91CB2817Q34076156-F8D14EB7-26C5-4940-840B-75F85AF431A0Q34603843-A89FA54F-E5A2-4BC6-A49F-8911E9E91DE4Q34654773-8F803A3D-1630-4097-B331-36AD6BC029CFQ35623187-97EA0081-CAF9-4553-B58A-E0D34B61BE3DQ35751497-0F9E86B5-0EA1-4FFB-8E9F-EE6DD70CBAD3Q35973755-4CE4CA5A-4E0F-4B53-A068-346ABB526D86Q35987917-E462E8BA-D0CC-42E4-9A3C-E974BC9161B2Q36579463-3F1700C9-D78D-4BFC-B838-D0E57E093B2AQ36837883-F203A3E3-A7EB-48AA-9896-45796B06AED4Q36962252-231FD972-3DC3-454C-BC59-B7C471C329A5Q37019719-00248B49-44F8-4B51-8D76-0B5A6B4F6078Q37167584-DC1A521F-E9AC-430F-9F1E-8AA593CC1617Q37289500-5059E017-F54F-43FA-AFA8-4271AC4E67F3Q37307356-2DCA43AF-52DC-4C4A-A749-953BE295B1FEQ37327168-FC12D52F-4DE9-4EE0-8E62-8A69169309B9Q37972978-FC424CE5-F5B0-4417-B4F9-DB488532BCB1Q39977956-077E2FC6-CC42-48B4-9845-9A88E1CD2AC1Q40202347-9E7245B1-ABE1-47E8-8EAE-1ABE789E9224Q40243911-06B4350E-2346-4AAC-950B-307612229BA5Q40601692-582933A6-DE37-416E-B735-E1C674A52796Q41900573-38896F1B-43D3-4D9B-8BF5-B1E21D174D89Q42505325-811E7614-D649-477B-88A8-651934C8A067Q43701650-CDBCE846-1DAE-4C7F-B568-40998856855EQ44182990-481F02F9-2D53-4B99-B073-F504FD69ADD4Q44185642-77299436-25B6-4C2B-85BD-175423D67022Q44369443-F486976F-8E45-4B10-8F33-ECCA24419B14Q44522497-8CDF8AA5-2205-4BB9-96E7-F29F36229562Q44764133-9C98D280-8157-4AC8-8313-53479AE227A5Q45108007-02DDA45E-4843-487F-AFBC-1EFAA0A69BA1Q50718257-56D3DD07-D67F-45D1-860E-81C4BF0A62EDQ58790122-32852B8D-9736-4D9C-97B0-17A31E926FE2
P2860
Beta-adrenergic receptors and receptor signaling in heart failure.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Beta-adrenergic receptors and receptor signaling in heart failure.
@ast
Beta-adrenergic receptors and receptor signaling in heart failure.
@en
type
label
Beta-adrenergic receptors and receptor signaling in heart failure.
@ast
Beta-adrenergic receptors and receptor signaling in heart failure.
@en
prefLabel
Beta-adrenergic receptors and receptor signaling in heart failure.
@ast
Beta-adrenergic receptors and receptor signaling in heart failure.
@en
P1476
Beta-adrenergic receptors and receptor signaling in heart failure
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.39.1.343
P577
1999-01-01T00:00:00Z